Novalar product donation

Nov. 30, 2010
Company has donated more than $100,000 worth of OraVerse product to National Children’s Oral Health Foundation.

SAN DIEGO, California--Novalar Pharmaceuticals, a specialty pharmaceutical company focused in dental, has announced the donation of more than $100,000 worth of OraVerse product to the National Children’s Oral Health Foundation.

To read more about Novalar, go to Novalar.

The NCOHF affiliate network is a consortium of more than 60 of America’s finest not-for-profit oral health programs dedicated to eliminating pediatric dental disease by offering quality, comprehensive dental services to underserved children.

“We are extremely pleased to make this donation and to be collaborating with NCOHF in its efforts to increase access to dental care for pediatric patients,” said Donna Janson, president & CEO of Novalar.

“Through this donation program, dentists within the network may effectively treat their patients with local anesthetics without the resulting lingering and unnecessary soft-tissue numbness, allowing them to more quickly return to their normal daily activities.”

For more information, go to

To comment on this subject, go to